REFERENCES
- Isager P, Østerlind A, Engholm G, Heegaard S, Lindegaard J, Overgaard J, Storm H H. Malignant melanoma in the ocular region in Denmark 1943–97. Incidence and validation study. Ophthalmic Epidemiology 2005; 12: 223–232, [PUBMED], [CSA]
- Seregard S. Long-term survival after ruthenium plaque radiotherapy for uveal melanoma. A meta-analysis of studies including 1,066 patients. Acta Ophthalmol Scand. 1999; 77: 414–417, [PUBMED], [CSA], [CROSSREF]
- The Collaborative Ocular Melanoma Study Group. Mortality in patients with small choroidal melanoma. COMS report no. 4. Arch Ophthalmol. 1997; 115: 886–893, [CSA]
- The Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. Arch Ophthalmol. 2001; 119: 969–982, COMS Report No. 18.[CSA]
- Diener-West M, Hawkins B S, Markowitz J A, Schachat A P. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol. 1992; 110: 245–250, [PUBMED], [CSA]
- Seddon J M, Gragoudas E S, Egan K M, Glynn R J, Howard S, Fante R G, Albert D M. Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology 1990; 97: 769–777, [PUBMED], [CSA]
- Castro J R, Char D H, Petti P L, Daftari I K, Quivey J M, Singh R P, Blakely E A, Phillips T L. 15 years experience with helium ion radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys. 1997; 39: 989–996, [PUBMED], [CSA], [CROSSREF]
- The Collaborative Ocular Melanoma Study Group. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24. Am J Ophthalmol. 2004; 138: 936–951, [CSA], [CROSSREF]
- Rones B, Zimmerman L E. The prognosis of primary tumors of the iris treated by iridectomy. Arch Ophthalmol. 1958; 60: 193–205, [CSA]
- Reese A B, Cleasby G W. The treatment of iris melanoma. Am J Ophthalmol. 1959; 47: 118–125, [PUBMED], [CSA]
- Ashton N, Wybar K. Primary tumours of the iris. Ophthalmologica 1966; 151: 97–113, [PUBMED], [CSA]
- Sunba M S, Rahi A H, Morgan G. Tumors of the anterior uvea. I. Metastasizing malignant melanoma of the iris. Arch Ophthalmol. 1980; 98: 82–85, [PUBMED], [CSA]
- Geisse L J, Robertson D M. Iris melanomas. Am J Ophthalmol. 1985; 99: 638–648, [PUBMED], [INFOTRIEVE], [CSA]
- Jensen O A. Malignant melanoma of the iris. A 25-year analysis of Danish cases. Eur J Ophthalmol. 1993; 3: 181–188, [PUBMED], [CSA]
- Shields C L, Shields J A, Materin M, Gershenbaum E, Singh A D, Smith A. Iris melanoma: risk factors for metastasis in 169 consecutive patients. Ophthalmology 2001; 108: 172–178, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Paridaens A D, Minassian D C, McCartney A C, Hungerford J L. Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases. Br J Ophthalmol. 1994; 78: 252–259, [PUBMED], [INFOTRIEVE], [CSA]
- Anastassiou G, Heiligenhaus A, Bechrakis N, Bader E, Bornfeld N, Steuhl K P. Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study. Br J Ophthalmol. 2002; 86: 163–167, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Shields C L, Shields J A, Gunduz K, Cater J, Mercado G V, Gross N, Lally B. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol. 2000; 118: 1497–1507, [PUBMED], [INFOTRIEVE], [CSA]
- Werschnik C, Lommatzsch P K. Long-term follow-up of patients with conjunctival melanoma. Am J Clin Oncol. 2002; 25: 248–255, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Liesegang T J, Campbell R J. Mayo Clinic experience with conjunctival melanomas. Arch Ophthalmol. 1980; 98: 1385–1389, [PUBMED], [INFOTRIEVE], [CSA]
- de Wolff-Rouendaal D. Conjunctival Melanoma in the Netherlands: a clinico-pathological and follow-up study. Thesis, University of Leiden ed., Katwijk 1990, All in BV
- Norregaard J C, Gerner N, Jensen O A, Prause J U. Malignant melanoma of the conjunctiva: occurrence and survival following surgery and radiotherapy in a Danish population. Graefes Arch Clin Exp Ophthalmol. 1996; 234: 569–572, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Singh A D, Topham A. Survival rates with uveal melanoma in the United States: 1973–1997. Ophthalmology 2003; 110: 962–965, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Raivio I. Uveal melanoma in Finland. Acta Ophthalmol (Copenh) 1977, Suppl 133, (thesis)[CSA]
- Isager P, Ehlers N, Overgaard J. Have choroidal and ciliary body melanomas changed during the period 1955–2000?. Acta Ophthalmol Scand. 2004; 82: 509–516, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jensen O A. Malignant melanomas of the human uvea: 25-year follow-up of cases in Denmark, 1943–1952. Acta Ophthalmol. (Copenh) 1982; 60: 161–182, [CSA]
- Bergman L, Seregard S, Nilsson B, Lundell G, Ringborg U, Ragnarsson-Olding B. Uveal melanoma survival in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci. 2003; 44: 3282–3287, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- McGalliard J N, Johnston P B. A study of iris melanoma in Northern Ireland. Br J Ophthalmol. 1989; 73: 591–595, [PUBMED], [INFOTRIEVE], [CSA]
- Seregard S, Kock E. Conjunctival malignant melanoma in Sweden 1969–91. Acta Ophthalmol. (Copenh) 1992; 70: 289–296, [CSA]
- Conley J. Is melanoma changing?. Otolaryngol Head Neck Surg. 1991; 104: 327–332, [PUBMED], [INFOTRIEVE], [CSA]
- Mansson-Brahme E, Johansson H, Larsson O, Rutqvist L E, Ringborg U. Trends in incidence of cutaneous malignant melanoma in a Swedish population 1976–1994. Acta Oncol. 2002; 41: 138–146, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- MacKie R M, Bray C A, Hole D J, Morris A, Nicolson M, Evans A, Doherty V, Vestey J. Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet 2002; 360: 587–591, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Seregard S, Kock E. Prognostic indicators following enucleation for posterior uveal melanoma. A multivariate analysis of long-term survival with minimized loss to follow-up. Acta Ophthalmol Scand 1995; 73: 340–344, [PUBMED], [INFOTRIEVE], [CSA]
- Kroll S, Char D H, Quivey J, Castro J. A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma. Ophthalmology 1998; 105: 2035–2045, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- McLean I W, Ainbinder D J, Gamel J W, McCurdy J B. Choroidal-ciliary body melanoma. A multivariate survival analysis of tumor location. Ophthalmology 1995; 102: 1060–1064, [PUBMED], [INFOTRIEVE], [CSA]
- Isager P, Ehlers N, Overgaard J. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas. Acta Ophthalmol Scand 2004; 82: 517–525, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Demirci H, Shields C L, Shields J A, Eagle R C, Jr., Honavar S G. Diffuse iris melanoma: a report of 25 cases. Ophthalmology 2002; 109: 1553–1560, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Folberg R, McLean I W, Zimmerman L E. Malignant melanoma of the conjunctiva. Hum Pathol. 1985; 16: 136–143, [PUBMED], [INFOTRIEVE], [CSA]
- Augsburger J J, Schneider S, Freire J, Brady L W. Survival following enucleation versus plaque radiotherapy in statistically matched subgroups of patients with choroidal melanomas: results in patients treated between 1980 and 1987. Graefes Arch Clin Exp Ophthalmol 1999; 237: 558–567, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Woll E, Bedikian A, Legha S S. Uveal melanoma: natural history and treatment options for metastatic disease. Melanoma Res. 1999; 9: 575–581, [PUBMED], [INFOTRIEVE], [CSA]
- World Health Organization. International Classification of Diseases for Oncology (ICD-O). First edition ed. World Health Organization, Geneva 1976
- World Health Organization. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, 1955. Seventh revision ed. World Health Organization, Geneva 1957
- Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982; 38: 933–942, [PUBMED], [INFOTRIEVE], [CSA]
- Therneau T, Sick J, Bergstralh E, Offors J. Expected survival on hazard rates. Technical Report no. 52, MAYO Foundation, Rochester, Minnesota 1994
- Buch P. Befolkningsudvikling og Sundhedsforhold 1901–60. Det Statistiske Departement, Danmarks Statistik (Statistics Denmark), København 1966; 102
- Danmarks Statistik (Statistics Denmark). Befolkningens Bevægelser (Vital Statistics). Annual Publications: 1963–1982, 1963
- Statistics Denmark. 2003, www.statbank.dk Internet
- Storm H H. Validitet af danske dødsattester for cancerpatienter 1977. København 1984; 1–66
- Augsburger J J, Gamel J W. Clinical prognostic factors in patients with posterior uveal malignant melanoma. Cancer 1990; 66: 1596–1600, [PUBMED], [INFOTRIEVE], [CSA]
- Seregard S, Spangberg B, Juul C, Oskarsson M. Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma. Ophthalmology 1998; 105: 485–491, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jakobiec F A, Silbert G. Are most iris “melanomas” really nevi? A clinicopathologic study of 189 lesions. Arch Ophthalmol 1981; 99: 2117–2132, [PUBMED], [INFOTRIEVE], [CSA]